Aboriginal Health Services - Section 100 - Frequently Asked Questions Remote Area Aboriginal Health Services (RAAHS) Program

Information Sheets on the s100 Remote Area Aboriginal Health Services (RAAHS) Program

Page last updated: 09 April 2019

Supply of Pharmaceutical Benefit Scheme medicines to remote area Aboriginal Health Services

Responses to frequently asked questions

1. What do these arrangements seek to achieve?

These arrangements seek to address barriers experienced by people living in remote areas of Australia in accessing essential medicines through the PBS.

These barriers can be summarised as:
  • delays experienced in obtaining medicines with the standard prescription-based supply chain;
  • difficulties experienced in demonstrating eligibility for concessional benefits under the PBS; and
  • affordability issues.

2. Who is eligible to receive PBS medicines under these arrangements?

The arrangements are targeted at clients of eligible remote area Aboriginal Health Services. A client may or may not identify as an Aboriginal or Torres Strait Islander person.

3. Why are these arrangements restricted to remote areas?

There is evidence to suggest that a proportion of Aboriginal and Torres Strait Islander people in a number of areas of Australia incur difficulties in accessing mainstream programs. However, barriers are greatest in remote areas where basic services may not be available in close proximity to established centres of population and where demand for services exceeds the resources, structures and personnel required to meet that need. Isolation from supply points such as community pharmacies and sporadic medical coverage have hindered appropriate access in these areas to essential medicines.

4. What about the supply of non-PBS medicines?

These arrangements cover essential, cost effective medicines which are currently listed in the Schedule of Pharmaceutical Benefits. Excluding:
  1. medicines that can only be supplied under s100 of the Act, including Highly Specialised Drugs.
  2. emergency drug (Prescriber's Bag) supplies.
  3. Medicines which are Schedule 8 (‘Controlled drugs, eg Opioid Analgesics’), as defined by the drugs and poisons legislation in the relevant State or Territory..

5. What safeguards are there for controlling bulk medicines in remote communities?

Participating remote area services must comply with strict conditions, including compliance with State/Territory requirements relating to the prescribing, storage and supply of medicines. Services not meeting these requirements are not approved to participate.

6. Who can supply medicines to remote health services under these arrangements?

Medicines are supplied by approved community pharmacies and approved hospital authorities.

7. Why are community pharmacies involved?

Community pharmacies are well placed to act as local supply points for medicines, and to provide value adding services to remote communities such as medicines information, medication reviews and education.

8. Is participation in these arrangements compulsory?

No. Some services may wish to remain with their current supply arrangements.

9. When did these arrangements begin?

Participation in these arrangements was offered to the Aboriginal community-controlled sector in January 1999.

Remote services that are operated by the States and Territories are also able to participate, following commitments by State/Territory governments to maintain current outlays directed towards healthcare services for Aboriginal and Torres Strait Islander peoples.

Currently more than 160 community controlled and state/territory operated remote health services benefit from improved access to PBS medicines through participation in these arrangements.

Further information, please email the Department (S100-remotepharmsupport@health.gov.au)